01/23/2026
A University of Iowa researcher is leading efforts to develop new treatments for a rare and extremely aggressive pediatric brain cancer.
“The pediatric patients I have had the privilege of helping treat have had a profound impact on me, both in my training and in my current clinical position, as these patients are incredibly resilient in the midst of a scary time,” says Michelle Howard, PhD, assistant professor of radiation oncology.
Howard and her team are leading efforts to develop treatments for DIPG, a pediatric cancer with a median five-year survival rate of only 2%.
Read more about Howard’s research at the link in the comments.